American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

NURO

NURO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

NURO historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of NURO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NURO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NURO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NURO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in NURO holdings by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by NURO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jul 24, 2008 Issue: Health Issues
  • $20,000 Feb 14, 2008 Issue: Medicare/Medicaid
  • $20,000 Aug 14, 2007 Issue: Medicare/Medicaid
  • $40,000 Aug 03, 2007 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for NURO

Quiver Logo

No former government officials on record as having lobbied for NURO

Revolving Door Dashboard
Corporate Lobbying

NURO Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

NURO Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NURO Income Statement
NURO Balance Sheet
NURO Cash Flow
U.S. Patents

New NURO patent grants

  • Patent Title: Nerve stimulation (tens) device Sep. 08, 2026
  • Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Feb. 17, 2026
  • Patent Title: Apparatus and method for the automated control of transcutaneous electrical nerve stimulation based on current and forecasted weather conditions Jul. 22, 2025
  • Patent Title: Nerve conduction assessment device May. 20, 2025
  • Patent Title: “smart” electrode assembly for transcutaneous electrical nerve stimulation (tens) Nov. 05, 2024
  • Patent Title: Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation Jan. 30, 2024
  • Patent Title: Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means Aug. 22, 2023
  • Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Aug. 08, 2023
  • Patent Title: Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement Nov. 29, 2022
  • Patent Title: Transcutaneous electrical nerve stimulation (tens) device Jul. 19, 2022
  • Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (tens) using the same Mar. 01, 2022
  • Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state Feb. 15, 2022
  • Patent Title: Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection Feb. 15, 2022
  • Patent Title: “smart” electrode assembly for transcutaneous electrical nerve stimulation (tens) Feb. 01, 2022
  • Patent Title: Detecting cutaneous electrode peeling using electrode-skin impedance Dec. 07, 2021
  • Patent Title: Apparatus and method for the automated control of transcutaneous electrical nerve stimulation based on current and forecasted weather conditions Jul. 13, 2021
  • Patent Title: Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means Mar. 09, 2021
  • Patent Title: Apparatus and method for the automated measurement of sural nerve conduction velocity and amplitude Jan. 05, 2021
  • Patent Title: Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement Dec. 15, 2020
  • Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Sep. 22, 2020
  • Patent Title: Transcutaneous electrical nerve stimulation device strap Nov. 05, 2019
  • Patent Title: Transcutaneous electrical nerve stimulation (tens) device Oct. 08, 2019
  • Patent Title: Apparatus for transcutaneous electrical nerve stimulation Oct. 01, 2019
  • Patent Title: Transcutaneous electrical nerve stimulation device Aug. 27, 2019
  • Patent Title: Bioelectrode Jun. 11, 2019
  • Patent Title: Transcutaneous electrical nerve stimulation (tens) device Jan. 01, 2019
  • Patent Title: Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same Nov. 28, 2017
  • Patent Title: Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (tens) using the same Aug. 15, 2017
  • Patent Title: Measuring the “on-skin” time of a transcutaneous electrical nerve stimulator (tens) device in order to minimize skin irritation due to excessive uninterrupted wearing of the same Jun. 13, 2017
  • Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation May. 23, 2017
  • Patent Title: Detecting cutaneous electrode peeling using electrode-skin impedance Oct. 25, 2016
  • Patent Title: Apparatus and method for the automated measurement of sural nerve conduction velocity and amplitude Nov. 03, 2015
  • Patent Title: Estimation of f-wave times of arrival (toa) for use in the assessment of neuromuscular function Nov. 03, 2015
  • Patent Title: Transcutaneous electrical nerve stimulation (tens) device Aug. 04, 2015
  • Patent Title: Method and apparatus for quantitative nerve localization May. 26, 2015
  • Patent Title: Automated stimulus artifact removal for nerve conduction studies Apr. 21, 2015
  • Patent Title: Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation Feb. 03, 2015
  • Patent Title: Transcutaneous electrical nerve stimulation device Oct. 28, 2014
  • Patent Title: Method for automated analysis of submaximal f-waves Dec. 04, 2012
  • Patent Title: Bioelectrode Oct. 16, 2012
  • Patent Title: Bioelectrode Oct. 16, 2012
  • Patent Title: Detection and classification of neuromuscular late wave activity for the assessment of neuromuscular function Dec. 13, 2011
  • Patent Title: Disposable needle electrode with identification, and alterable, connector interface Oct. 04, 2011
  • Patent Title: Method and apparatus for determining optimal neuromuscular detection sites, novel diagnostic biosensor array formed in accordance with the same, and novel method for testing a patient using the novel diagnostic biosensor array Mar. 29, 2011
  • Patent Title: Disposable, multi-purpose cardiovascular autonomic neuropathy testing device Mar. 22, 2011
  • Patent Title: Motor unit number estimation (mune) for the assessment of neuromuscular function Dec. 07, 2010
  • Patent Title: Method for automated detection of a-waves Jul. 06, 2010
  • Patent Title: Device for receiving and collecting biosignals from electrodes and transmitting same May. 11, 2010
  • Patent Title: Charger Mar. 23, 2010
  • Patent Title: Bioelectrode Feb. 02, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NURO from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NURO News

Recent insights relating to NURO

CNBC Recommendations

Recent picks made for NURO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NURO

NURO Analyst Ratings

NURO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NURO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NURO stock a Buy, Sell, or Hold?

  • What is the price target for $NURO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NURO Top Shareholders
Shareholder
Shares Held
NURO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NURO stock?

  • Who owns the most shares of $NURO stock?

  • What funds own $NURO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NURO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NURO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NURO

No description available

NURO (NURO) Historical Stock Prices

NURO (NURO) closed at $4.58 on May 1, 2025. Over the past year its adjusted close ranged from $2.79 to $4.59. Daily prices go back to January 2, 2014, 2,846 trading days in all.

  • 1 month+3.85%
  • 3 months+8.79%
  • Year to date+15.37%
  • 1 year+3.15%
  • 3 years-81.04%
  • 5 years-78.48%
  • Max-99.94%
See every congressional and insider trade on the NURO price chart

Quiver Premium charts NURO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
May 1, 2025 4.36 4.69 4.33 4.58 4.58 35,587
Apr 30, 2025 4.34 4.37 4.34 4.36 4.36 1,897
Apr 29, 2025 4.26 4.40 4.26 4.36 4.36 20,834
Apr 28, 2025 4.45 4.45 4.33 4.36 4.36 2,340
Apr 25, 2025 4.38 4.41 4.33 4.34 4.34 1,331
Apr 23, 2025 4.38 4.38 4.38 4.38 4.38 233
Apr 22, 2025 4.28 4.38 4.28 4.35 4.35 659
Apr 21, 2025 4.30 4.33 4.30 4.32 4.32 3,442
Apr 17, 2025 4.28 4.43 4.28 4.42 4.42 1,394
Apr 16, 2025 4.33 4.34 4.33 4.34 4.34 663
Apr 15, 2025 4.32 4.38 4.32 4.38 4.38 693
Apr 14, 2025 4.42 4.42 4.32 4.37 4.37 1,196
Apr 10, 2025 4.40 4.45 4.40 4.41 4.41 1,570
Apr 9, 2025 4.29 4.38 4.26 4.33 4.33 5,107
Apr 8, 2025 4.42 4.43 4.40 4.40 4.40 7,609
Apr 7, 2025 4.32 4.39 4.32 4.38 4.38 3,360
Apr 4, 2025 4.42 4.44 4.38 4.41 4.41 16,672
Apr 3, 2025 4.45 4.45 4.42 4.42 4.42 1,508
Apr 2, 2025 4.42 4.42 4.42 4.42 4.42 484
Apr 1, 2025 4.41 4.41 4.41 4.41 4.41 478
Mar 31, 2025 4.40 4.50 4.40 4.42 4.42 3,640
Mar 28, 2025 4.42 4.56 4.42 4.43 4.43 2,732
Mar 27, 2025 4.41 4.52 4.41 4.51 4.51 1,206
Mar 26, 2025 4.42 4.42 4.42 4.42 4.42 476
Mar 25, 2025 4.48 4.58 4.45 4.45 4.45 10,236
Mar 24, 2025 4.51 4.65 4.50 4.59 4.59 9,269
Mar 21, 2025 4.60 4.60 4.42 4.51 4.51 9,338
Mar 20, 2025 4.38 4.59 4.38 4.58 4.58 13,751
Mar 19, 2025 4.39 4.39 4.39 4.39 4.39 1,085
Mar 18, 2025 4.40 4.44 4.39 4.39 4.39 1,285
Mar 17, 2025 4.35 4.43 4.35 4.41 4.41 4,925
Mar 14, 2025 4.36 4.37 4.35 4.37 4.37 1,074
Mar 13, 2025 4.39 4.39 4.37 4.37 4.37 1,857
Mar 12, 2025 4.36 4.37 4.35 4.37 4.37 1,053
Mar 11, 2025 4.35 4.37 4.35 4.35 4.35 1,809
Mar 10, 2025 4.36 4.36 4.36 4.36 4.36 390
Mar 7, 2025 4.37 4.38 4.36 4.38 4.38 8,362
Mar 6, 2025 4.38 4.38 4.38 4.38 4.38 441
Mar 5, 2025 4.37 4.38 4.33 4.37 4.37 7,899
Mar 4, 2025 4.37 4.38 4.36 4.38 4.38 1,661
Mar 3, 2025 4.36 4.42 4.36 4.36 4.36 26,232
Feb 28, 2025 4.37 4.39 4.36 4.38 4.38 9,075
Feb 27, 2025 4.40 4.40 4.38 4.39 4.39 7,278
Feb 26, 2025 4.40 4.40 4.38 4.38 4.38 1,241
Feb 25, 2025 4.45 4.45 4.37 4.38 4.38 20,154
Feb 24, 2025 4.50 4.50 4.38 4.38 4.38 3,767
Feb 21, 2025 4.52 4.54 4.37 4.39 4.39 13,204
Feb 20, 2025 4.37 4.42 4.37 4.42 4.42 995
Feb 19, 2025 4.35 4.45 4.35 4.41 4.41 31,314
Feb 18, 2025 4.37 4.37 4.36 4.36 4.36 4,656
Feb 14, 2025 4.36 4.38 4.36 4.38 4.38 4,816
Feb 13, 2025 4.37 4.38 4.37 4.38 4.38 3,650
Feb 12, 2025 4.37 4.38 4.37 4.38 4.38 4,053
Feb 11, 2025 4.37 4.38 4.37 4.38 4.38 17,226
Feb 10, 2025 4.38 4.39 4.37 4.37 4.37 15,353
Feb 7, 2025 4.40 4.40 4.36 4.37 4.37 11,005
Feb 6, 2025 4.40 4.40 4.35 4.38 4.38 4,561
Feb 5, 2025 4.37 4.40 4.34 4.35 4.35 7,983
Feb 4, 2025 4.33 4.38 4.32 4.38 4.38 7,124
Feb 3, 2025 4.35 4.35 4.16 4.32 4.32 10,784
Jan 31, 2025 4.25 4.39 4.24 4.31 4.31 70,305
Jan 30, 2025 4.21 4.21 4.15 4.21 4.21 19,988
Jan 29, 2025 4.21 4.24 4.18 4.18 4.18 27,565
Jan 28, 2025 4.21 4.21 4.16 4.19 4.19 8,956
Jan 27, 2025 4.12 4.22 4.12 4.21 4.21 13,852
Jan 24, 2025 4.04 4.24 4.04 4.21 4.21 40,596
Jan 23, 2025 3.99 4.05 3.99 4.03 4.03 39,901
Jan 22, 2025 4.10 4.10 3.98 4.00 4.00 44,333
Jan 21, 2025 4.05 4.11 4.05 4.06 4.06 44,713
Jan 17, 2025 4.04 4.05 3.98 4.05 4.05 1,538
Jan 16, 2025 4.02 4.05 3.93 3.93 3.93 25,535
Jan 15, 2025 4.10 4.10 3.96 4.02 4.02 15,298
Jan 14, 2025 4.10 4.10 3.92 3.98 3.98 31,883
Jan 13, 2025 3.97 4.06 3.96 4.01 4.01 5,113
Jan 10, 2025 3.97 4.06 3.97 3.97 3.97 3,910
Jan 8, 2025 4.10 4.13 4.02 4.04 4.04 4,465
Jan 7, 2025 3.97 4.05 3.93 4.05 4.05 14,446
Jan 6, 2025 3.99 3.99 3.91 3.97 3.97 11,543
Jan 3, 2025 3.96 3.97 3.90 3.93 3.93 12,947
Jan 2, 2025 3.97 4.01 3.86 3.93 3.93 18,832
Dec 31, 2024 3.91 3.97 3.88 3.97 3.97 5,520
Dec 30, 2024 3.94 3.96 3.86 3.96 3.96 15,455
Dec 27, 2024 3.96 3.96 3.89 3.94 3.94 15,052
Dec 26, 2024 3.92 4.00 3.86 3.92 3.92 40,928
Dec 24, 2024 3.94 3.94 3.90 3.92 3.92 4,840
Dec 23, 2024 3.85 3.95 3.82 3.95 3.95 26,593
Dec 20, 2024 3.95 4.00 3.80 3.90 3.90 28,343
Dec 19, 2024 3.92 3.97 3.77 3.90 3.90 78,213
Dec 18, 2024 4.09 4.11 3.75 3.84 3.84 217,773
Dec 17, 2024 3.75 3.84 3.63 3.77 3.77 104,562
Dec 16, 2024 3.69 4.07 3.69 3.90 3.90 7,445
Dec 13, 2024 3.75 3.98 3.63 3.81 3.81 6,070
Dec 12, 2024 3.90 3.90 3.88 3.90 3.90 2,644
Dec 11, 2024 4.00 4.00 3.83 4.00 4.00 8,087
Dec 10, 2024 4.15 4.15 4.02 4.03 4.03 1,883
Dec 9, 2024 4.28 4.28 3.85 4.11 4.11 26,156
Dec 6, 2024 4.14 4.32 4.09 4.09 4.09 2,440
Dec 5, 2024 4.34 4.34 4.04 4.31 4.31 2,039
Dec 4, 2024 4.13 4.29 3.97 4.14 4.14 6,257
Dec 3, 2024 4.32 4.33 4.00 4.05 4.05 4,948
Dec 2, 2024 4.27 4.40 4.27 4.31 4.31 2,861
Nov 29, 2024 4.34 4.42 4.20 4.27 4.27 29,386
Nov 27, 2024 4.49 4.49 4.24 4.30 4.30 9,273
Nov 26, 2024 4.19 4.39 4.19 4.25 4.25 9,445
Nov 25, 2024 4.30 4.50 4.16 4.22 4.22 10,977
Nov 22, 2024 4.36 4.60 4.25 4.25 4.25 17,945
Nov 21, 2024 4.20 4.46 4.13 4.15 4.15 7,357
Nov 20, 2024 3.96 4.56 3.96 4.34 4.34 28,618
Nov 19, 2024 3.74 3.98 3.70 3.97 3.97 22,283
Nov 18, 2024 3.81 3.94 3.59 3.80 3.80 11,824
Nov 15, 2024 3.81 3.93 3.64 3.93 3.93 2,990
Nov 14, 2024 3.78 3.92 3.59 3.79 3.79 9,882
Nov 13, 2024 3.68 3.74 3.56 3.59 3.59 27,547
Nov 12, 2024 3.78 3.80 3.59 3.68 3.68 3,732
Nov 11, 2024 3.73 3.76 3.70 3.76 3.76 3,046
Nov 8, 2024 3.77 3.84 3.64 3.72 3.72 19,870
Nov 7, 2024 3.70 4.00 3.70 3.83 3.83 31,103
Nov 6, 2024 3.58 3.87 3.56 3.61 3.61 11,116
Nov 5, 2024 3.97 3.97 3.22 3.55 3.55 18,785
Nov 4, 2024 3.93 4.09 3.71 3.81 3.81 96,477
Nov 1, 2024 4.01 4.73 3.92 4.00 4.00 49,164
Oct 31, 2024 4.07 4.13 3.90 4.01 4.01 6,703
Oct 30, 2024 4.03 4.22 3.80 4.03 4.03 41,738
Oct 29, 2024 4.04 4.04 4.04 4.04 4.04 361
Oct 28, 2024 4.00 4.30 3.89 4.01 4.01 6,326
Oct 25, 2024 4.05 4.09 3.90 4.05 4.05 6,146
Oct 24, 2024 4.22 4.49 3.85 4.05 4.05 49,704
Oct 23, 2024 4.39 4.39 4.26 4.39 4.39 2,921
Oct 22, 2024 4.48 4.56 4.36 4.39 4.39 10,622
Oct 21, 2024 4.58 4.60 4.35 4.55 4.55 16,693
Oct 18, 2024 4.58 4.69 4.51 4.58 4.58 8,181
Oct 17, 2024 4.66 4.66 4.51 4.51 4.51 13,689
Oct 16, 2024 4.32 4.70 4.28 4.57 4.57 20,615
Oct 15, 2024 4.04 4.30 4.04 4.27 4.27 15,627
Oct 14, 2024 4.02 4.20 3.96 4.08 4.08 8,673
Oct 11, 2024 4.15 4.15 3.99 4.06 4.06 13,977
Oct 10, 2024 4.05 4.17 3.92 4.15 4.15 12,851
Oct 9, 2024 4.04 4.18 4.00 4.01 4.01 14,436
Oct 8, 2024 4.05 4.19 3.85 4.19 4.19 33,674
Oct 7, 2024 4.09 4.20 4.09 4.12 4.12 8,855
Oct 4, 2024 4.16 4.16 4.09 4.14 4.14 1,617
Oct 3, 2024 4.22 4.25 4.07 4.07 4.07 6,755
Oct 2, 2024 4.10 4.24 3.98 4.20 4.20 10,649
Oct 1, 2024 3.93 4.20 3.93 4.18 4.18 11,060
Sep 30, 2024 4.06 4.19 3.97 3.97 3.97 16,766
Sep 27, 2024 4.18 4.18 3.86 3.93 3.93 12,402
Sep 26, 2024 3.96 4.25 3.89 4.00 4.00 33,469
Sep 25, 2024 3.92 4.16 3.87 4.10 4.10 27,017
Sep 24, 2024 4.01 4.22 3.89 3.89 3.89 27,507
Sep 23, 2024 3.98 4.27 3.98 4.02 4.02 43,829
Sep 20, 2024 3.80 3.93 3.65 3.93 3.93 18,363
Sep 19, 2024 3.81 3.94 3.65 3.82 3.82 15,713
Sep 18, 2024 4.05 4.18 3.69 3.81 3.81 50,509
Sep 17, 2024 3.98 4.13 3.78 4.05 4.05 19,101
Sep 16, 2024 3.80 4.08 3.80 4.02 4.02 12,774
Sep 13, 2024 4.05 4.05 3.83 4.00 4.00 15,797
Sep 12, 2024 3.96 4.11 3.96 4.05 4.05 32,706
Sep 11, 2024 3.86 3.99 3.86 3.99 3.99 13,172
Sep 10, 2024 3.79 4.01 3.65 3.92 3.92 14,125
Sep 9, 2024 3.66 4.02 3.65 3.73 3.73 9,063
Sep 6, 2024 3.98 4.02 3.63 3.77 3.77 10,894
Sep 5, 2024 3.83 4.02 3.82 3.82 3.82 11,451
Sep 4, 2024 3.74 3.93 3.70 3.87 3.87 41,782
Sep 3, 2024 3.93 3.93 3.80 3.80 3.80 1,827
Aug 30, 2024 3.79 3.84 3.63 3.82 3.82 18,114
Aug 29, 2024 3.78 4.00 3.78 3.88 3.88 9,292
Aug 28, 2024 3.96 4.04 3.70 3.79 3.79 13,218
Aug 27, 2024 3.82 3.95 3.81 3.90 3.90 8,213
Aug 26, 2024 3.60 3.90 3.56 3.80 3.80 21,324
Aug 23, 2024 3.43 3.65 3.42 3.53 3.53 14,818
Aug 22, 2024 3.62 3.62 3.58 3.60 3.60 2,948
Aug 21, 2024 3.59 3.60 3.52 3.54 3.54 3,052
Aug 20, 2024 3.56 3.59 3.44 3.59 3.59 11,478
Aug 19, 2024 3.46 3.63 3.37 3.59 3.59 21,499
Aug 16, 2024 3.24 3.44 3.11 3.35 3.35 20,072
Aug 15, 2024 3.33 3.61 3.18 3.34 3.34 87,979
Aug 14, 2024 2.92 3.43 2.92 3.43 3.43 35,036
Aug 13, 2024 2.81 2.98 2.66 2.87 2.87 23,315
Aug 12, 2024 2.80 2.81 2.71 2.79 2.79 5,867
Aug 9, 2024 2.95 2.98 2.87 2.92 2.92 11,038
Aug 8, 2024 2.99 3.04 2.97 2.98 2.98 12,556
Aug 7, 2024 3.25 3.35 2.97 2.97 2.97 60,873
Aug 6, 2024 3.25 3.80 3.15 3.16 3.16 91,990
Aug 5, 2024 3.46 3.85 3.35 3.54 3.54 73,363
Aug 1, 2024 3.51 3.65 3.51 3.53 3.53 6,243
Jul 31, 2024 3.71 3.74 3.50 3.64 3.64 57,105
Jul 30, 2024 3.57 3.61 3.52 3.54 3.54 23,296
Jul 29, 2024 3.73 3.73 3.61 3.61 3.61 3,313
Jul 26, 2024 3.69 3.70 3.60 3.70 3.70 1,134
Jul 25, 2024 3.56 3.71 3.52 3.71 3.71 3,875
Jul 24, 2024 3.51 3.70 3.51 3.70 3.70 9,299
Jul 23, 2024 3.63 3.72 3.52 3.60 3.60 17,213
Jul 22, 2024 3.78 3.78 3.63 3.63 3.63 2,091
Jul 19, 2024 3.69 3.80 3.68 3.80 3.80 3,481
Jul 18, 2024 3.75 3.75 3.65 3.69 3.69 5,704
Jul 17, 2024 3.68 3.70 3.68 3.69 3.69 4,368
Jul 16, 2024 3.58 3.72 3.58 3.71 3.71 9,456
Jul 15, 2024 3.62 3.75 3.50 3.69 3.69 13,586
Jul 12, 2024 3.77 3.82 3.70 3.70 3.70 9,966
Jul 11, 2024 3.82 3.82 3.65 3.65 3.65 2,070
Jul 10, 2024 3.61 4.10 3.61 3.71 3.71 18,065
Jul 9, 2024 3.60 3.65 3.60 3.65 3.65 4,821
Jul 8, 2024 3.61 3.93 3.61 3.77 3.77 13,344
Jul 5, 2024 3.73 3.73 3.70 3.70 3.70 3,135
Jul 3, 2024 3.60 3.73 3.60 3.73 3.73 2,928
Jul 2, 2024 3.62 3.73 3.60 3.60 3.60 5,220
Jul 1, 2024 3.73 3.73 3.64 3.64 3.64 1,253
Jun 28, 2024 3.69 3.69 3.69 3.69 3.69 620
Jun 27, 2024 3.63 3.75 3.61 3.71 3.71 4,672
Jun 26, 2024 3.71 3.71 3.70 3.70 3.70 1,238
Jun 25, 2024 3.78 3.80 3.65 3.71 3.71 27,063
Jun 24, 2024 3.76 3.82 3.66 3.80 3.80 5,528
Jun 21, 2024 3.81 3.81 3.70 3.71 3.71 20,282
Jun 20, 2024 3.74 3.83 3.72 3.80 3.80 10,174
Jun 18, 2024 3.77 3.80 3.71 3.73 3.73 8,553
Jun 17, 2024 3.70 3.77 3.69 3.77 3.77 3,064
Jun 14, 2024 3.84 3.84 3.69 3.69 3.69 3,508
Jun 13, 2024 3.83 3.84 3.71 3.72 3.72 9,811
Jun 12, 2024 3.80 3.87 3.80 3.86 3.86 8,625
Jun 11, 2024 3.82 3.86 3.80 3.80 3.80 6,576
Jun 10, 2024 3.69 3.87 3.69 3.87 3.87 6,878
Jun 7, 2024 3.84 3.85 3.81 3.81 3.81 2,728
Jun 6, 2024 3.83 3.87 3.73 3.77 3.77 2,985
Jun 5, 2024 3.66 3.84 3.66 3.83 3.83 12,517
Jun 4, 2024 3.80 3.86 3.75 3.75 3.75 3,220
Jun 3, 2024 3.82 3.83 3.77 3.79 3.79 11,322
May 31, 2024 3.70 3.86 3.66 3.83 3.83 11,573
May 30, 2024 3.75 3.87 3.70 3.80 3.80 9,698
May 29, 2024 3.80 4.01 3.73 3.73 3.73 6,827
May 28, 2024 3.89 4.00 3.69 3.98 3.98 7,279
May 24, 2024 3.80 3.96 3.80 3.96 3.96 3,909
May 23, 2024 3.72 3.97 3.72 3.85 3.85 2,451
May 22, 2024 3.74 3.85 3.64 3.84 3.84 9,938
May 21, 2024 3.90 3.91 3.65 3.82 3.82 7,588
May 20, 2024 4.00 4.02 3.91 3.98 3.98 7,971
May 17, 2024 4.04 4.08 3.97 4.04 4.04 2,196
May 16, 2024 4.09 4.19 3.81 4.10 4.10 15,775
May 15, 2024 4.39 4.54 4.01 4.19 4.19 38,649
May 14, 2024 4.45 4.55 4.31 4.41 4.41 35,172
May 13, 2024 4.50 4.58 4.35 4.54 4.54 15,139
May 10, 2024 4.48 4.67 4.42 4.46 4.46 11,376
May 9, 2024 4.54 4.55 4.41 4.41 4.41 3,382
May 8, 2024 4.40 4.43 4.32 4.43 4.43 5,300
May 7, 2024 4.29 4.55 4.25 4.40 4.40 15,134
May 6, 2024 4.47 4.66 4.25 4.40 4.40 30,437
May 3, 2024 4.40 4.45 4.28 4.30 4.30 21,219
May 2, 2024 4.50 4.50 4.30 4.47 4.47 12,705
May 1, 2024 4.35 4.52 4.21 4.44 4.44 25,475

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
NURO Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NURO, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation